Parkworth Wealth Management’s NRC Health Common Stock NRC Stock Holding History

Parkworth Wealth Management’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$269	Buy	+16	New	+$216	﹤0.01%	842

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Parkworth Wealth Management's NRC Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in NRC Health Common Stock (NRC) in Q2 2025: 16 shares worth $269. The stake represents ﹤0.01% of the portfolio and ranks #842 among its holdings.

126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

Parkworth Wealth Management held 16 shares of NRC Health Common Stock worth $269 as of Q2 2025.
NRC Health Common Stock was a new Parkworth Wealth Management position in Q2 2025.
NRC Health Common Stock made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #842 holding.
126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.